Concepedia

Tina V. Valdez

TV

Statistics

Publications

1

Citations

18

H-Index

1

Active since

2012

Affiliations

University of Pittsburgh(Current)

Tina V. Valdez is an author at University of Pittsburgh specializing in dose-limiting toxicity assessment, stable disease assessment, and sorafenib therapy.

Publications per year

2012–2012

1

Publications

1

Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer

Chadi Nabhan, Dana Villines, Tina V. Valdez et al. · British Journal of Cancer · 2012 · 18 citations · Full text

Pharmacy, Oncology, Pharmacology +16

1–1 of 1